CHICAGO

Why It Matters That
Zantac Contains NDMA

Premier Personal Injury Attorneys
What it matters that zantac contains NDMA?

The recent news coverage about the withdrawal of the popular heartburn medication Zantac and other ranitidine products from the shelves of drugstores around the nation is based on the finding of NDMA in the drugs. NDMA is considered a probable carcinogen (a cancer-causing chemical) by multiple national and international health organizations, and this makes these recent findings in Zantac significant.

The FDA’s Advice

The FDA shares the following important advice related to Zantac usage:

Anyone using over-the-counter Zantac or other ranitidine products should discontinue usage, dispose of any excess medication properly, and quit purchasing the medication – including compounded forms of ranitidine.

Anyone taking prescription ranitidine should discuss alternate treatment options with their healthcare providers – several safer options are available.

The Cancer Connection

Zantac and similar medications have been associated with several specific types of cancer that include (but are not limited to):

  • Kidney Cancer
  • Bladder Cancer
  • Liver Cancer
  • Prostate Cancer
  • Esphageal Cancer
  • Stomach Cancer
  • Colorectal Cancer
  • Kidney Cancer
  • Cancer

You took Zantac to help with your heartburn and/or related health concerns, and cancer is obviously a serious side effect that would have dissuaded you from using the medication in the first place if you’d only known.

If you or someone you love regularly took Zantac or another ranitidine product and later developed cancer, an experienced drug injury attorney may be able to help.

What’s your case worth? Submit for a free case review

Our Location

205 W. Randolph St., #610,
Chicago, IL 60606

GET DIRECTIONS

Know Your Rights!

RESOURCES LIBRARY